Wyeth Seeks Approval To Launch 2 Drugs In Japan By 2007 End (Japan)
This article was originally published in PharmAsia News
Executive Summary
Wyeth is seeking marketing approval to introduce two prescription drugs in Japan. The company will file a new drug application with the Japanese government for Tygacil and Viviant by the end of this year. Viviant is used for osteoporosis, while Tygacil is used to treat pneumonia and other infections. The new drug launches are part of Wyeth's aim to raise sales in Japan to $1 billion by 2010, nearly double that of 2006. (Click here for more - May Require Paid Subscription